An Open-Label Evaluation of the Dose Proportionality of OROS� Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
Clinical trial NCT00398957 · COMPLETED
Trial details
- NCT number
- NCT00398957
- Sponsor
- Alza Corporation, DE, USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.